Dawn Billie Jorgenson

Title: Dawn Billie Jorgenson: Innovator in Pediatric Health Technologies

Introduction

Dawn Billie Jorgenson is a notable inventor based in Seattle, WA, who has made significant contributions to pediatric health technologies. With a focus on improving the safety and care of infants, she holds 2 patents that address critical health issues.

Latest Patents

One of her latest inventions is a method and apparatus for monitoring and treating sudden infant death syndrome (SIDS). This innovative device is designed to monitor an infant for the onset of SIDS, detect its symptoms, and provide immediate treatment. The apparatus includes a data gatherer for monitoring infant parameters, a controller for communication, an energy source for powering the device, and an alarm system to alert caregivers. The method of operation involves continuous monitoring and alerting caretakers when symptoms arise.

Another significant patent is a method and apparatus for reducing defibrillation energy. This energy reduction unit is designed to be connected to an external defibrillator, specifically for pediatric patients. It includes an attenuator that partially dissipates energy produced by the defibrillator, ensuring that the energy delivered is appropriate for infants and children under eight years old. The unit also features a presence-detect function to modify ECG signal analysis based on the patient's age.

Career Highlights

Dawn Jorgenson is currently employed at Agilent Technologies, Inc., where she continues to innovate in the field of medical technology. Her work focuses on developing solutions that enhance the safety and effectiveness of medical devices for children.

Collaborations

Throughout her career, Jorgenson has collaborated with notable colleagues, including Bradford Evan Gliner and Carlton B Morgan. These partnerships have contributed to her success in developing impactful health technologies.

Conclusion

Dawn Billie Jorgenson is a pioneering inventor whose work in pediatric health technologies has the potential to save lives and improve care for infants. Her innovative patents reflect her commitment to enhancing medical safety and efficacy for the youngest patients.